-
1
-
-
84858046578
-
Neuropathological alterations in Alzheimer disease
-
Neuropathological alterations in Alzheimer disease. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT, Cold Spring Harb Perspect Biol 2011 3 1 23
-
(2011)
Cold Spring Harb Perspect Biol
, vol.3
, pp. 1-23
-
-
Serrano-Pozo, A.1
Frosch, M.P.2
Masliah, E.3
Hyman, B.T.4
-
3
-
-
0035100888
-
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
-
11240971
-
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Biomarkers Definitions Working Group, Clin Pharmacol Ther 2001 69 89 95 11240971
-
(2001)
Clin Pharmacol Ther
, vol.69
, pp. 89-95
-
-
Definitions Working Group, B.1
-
4
-
-
72049130805
-
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
-
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ, Lancet Neurol 2009 9 119 128
-
(2009)
Lancet Neurol
, vol.9
, pp. 119-128
-
-
Jack, C.R.1
Knopman, D.S.2
Jagust, W.J.3
Shaw, L.M.4
Aisen, P.S.5
Weiner, M.W.6
Petersen, R.C.7
Trojanowski, J.Q.8
-
5
-
-
77949423619
-
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
-
10.1038/nrneurol.2010.4 20157306
-
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Blennow K, Hampel H, Weiner M, Zetterberg H, Nat Rev Neurol 2010 6 131 144 10.1038/nrneurol.2010.4 20157306
-
(2010)
Nat Rev Neurol
, vol.6
, pp. 131-144
-
-
Blennow, K.1
Hampel, H.2
Weiner, M.3
Zetterberg, H.4
-
6
-
-
82955243732
-
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
-
10.1212/WNL.0b013e31823b9c5e 22131541
-
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Rabinovici GD, Rosen HJ, Alkalay A, Kornak J, Furst AJ, Agarwal N, Mormino EC, O'Neil JP, Janabi M, Karydas A, Growdon ME, Jang JY, Huang EJ, Dearmond SJ, Trojanowski JQ, Grinberg LT, Gorno-Tempini ML, Seeley WW, Miller BL, Jagust WJ, Neurology 2011 77 2034 2042 10.1212/WNL.0b013e31823b9c5e 22131541
-
(2011)
Neurology
, vol.77
, pp. 2034-2042
-
-
Rabinovici, G.D.1
Rosen, H.J.2
Alkalay, A.3
Kornak, J.4
Furst, A.J.5
Agarwal, N.6
Mormino, E.C.7
O'Neil, J.P.8
Janabi, M.9
Karydas, A.10
Growdon, M.E.11
Jang, J.Y.12
Huang, E.J.13
Dearmond, S.J.14
Trojanowski, J.Q.15
Grinberg, L.T.16
Gorno-Tempini, M.L.17
Seeley, W.W.18
Miller, B.L.19
Jagust, W.J.20
more..
-
7
-
-
55849121534
-
Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia
-
10.1002/ana.21451 18991338
-
Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia. Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, O'Neil JP, Lal RA, Dronkers NF, Miller BL, Gorno-Tempini ML, Ann Neurol 2008 64 388 401 10.1002/ana.21451 18991338
-
(2008)
Ann Neurol
, vol.64
, pp. 388-401
-
-
Rabinovici, G.D.1
Jagust, W.J.2
Furst, A.J.3
Ogar, J.M.4
Racine, C.A.5
Mormino, E.C.6
O'Neil, J.P.7
Lal, R.A.8
Dronkers, N.F.9
Miller, B.L.10
Gorno-Tempini, M.L.11
-
8
-
-
0035824167
-
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome
-
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, Welsh-Bohmer KA, Alavi A, Clark CM, Salmon E, de Leon MJ, Mielke R, Cummings JL, Kowell AP, Gambhir SS, Hoh CK, Phelps ME, JAMA 2001 286 2120 2127 10.1001/jama.286.17.2120 11694153 (Pubitemid 34041597)
-
(2001)
Journal of the American Medical Association
, vol.286
, Issue.17
, pp. 2120-2127
-
-
Silverman, D.H.S.1
Small, G.W.2
Chang, C.Y.3
Lu, C.S.4
Kung De Aburto, M.A.5
Chen, W.6
Czernin, J.7
Rapoport, S.I.8
Pietrini, P.9
Alexander, G.E.10
Schapiro, M.B.11
Jagust, W.J.12
Hoffman, J.M.13
Welsh-Bohmer, K.A.14
Alavi, A.15
Clark, C.M.16
Salmon, E.17
De Leon, M.J.18
Mielke, R.19
Cummings, J.L.20
Kowell, A.P.21
Gambhir, S.S.22
Hoh, C.K.23
Phelps, M.E.24
more..
-
9
-
-
79956076567
-
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
10.1016/j.jalz.2011.03.004 21514247
-
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH, Alzheimers Dement 2011 7 257 262 10.1016/j.jalz.2011.03.004 21514247
-
(2011)
Alzheimers Dement
, vol.7
, pp. 257-262
-
-
Jack Jr., C.R.1
Albert, M.S.2
Knopman, D.S.3
McKhann, G.M.4
Sperling, R.A.5
Carrillo, M.C.6
Thies, B.7
Phelps, C.H.8
-
10
-
-
0026597063
-
Alzheimer's disease: The amyloid cascade hypothesis
-
10.1126/science.1566067 1566067
-
Alzheimer's disease: the amyloid cascade hypothesis. Hardy JA, Higgins GA, Science 1992 256 184 185 10.1126/science.1566067 1566067
-
(1992)
Science
, vol.256
, pp. 184-185
-
-
Hardy, J.A.1
Higgins, G.A.2
-
11
-
-
0036861112
-
Testing times for the amyloid cascade hypothesis
-
DOI 10.1016/S0197-4580(02)00042-8, PII S0197458002000428
-
Testing times for the 'amyloid cascade hypothesis'. Hardy J, Neurobiol Aging 2002 23 1073 1074 10.1016/S0197-4580(02)00042-8 12470803 (Pubitemid 35447788)
-
(2002)
Neurobiology of Aging
, vol.23
, Issue.6
, pp. 1073-1074
-
-
Hardy, J.1
-
12
-
-
33847662852
-
Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid β-peptide
-
DOI 10.1038/nrm2101, PII NRM2101
-
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Haass C, Selkoe DJ, Nat Rev Mol Cell Biol 2007 8 101 112 10.1038/nrm2101 17245412 (Pubitemid 46432529)
-
(2007)
Nature Reviews Molecular Cell Biology
, vol.8
, Issue.2
, pp. 101-112
-
-
Haass, C.1
Selkoe, D.J.2
-
13
-
-
43849083580
-
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
-
DOI 10.1093/brain/awn016
-
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST, Brain 2008 131 1630 1645 10.1093/brain/awn016 18339640 (Pubitemid 351806448)
-
(2008)
Brain
, vol.131
, Issue.6
, pp. 1630-1645
-
-
Ikonomovic, M.D.1
Klunk, W.E.2
Abrahamson, E.E.3
Mathis, C.A.4
Price, J.C.5
Tsopelas, N.D.6
Lopresti, B.J.7
Ziolko, S.8
Bi, W.9
Paljug, W.R.10
Debnath, M.L.11
Hope, C.E.12
Isanski, B.A.13
Hamilton, R.L.14
DeKosky, S.T.15
-
14
-
-
80053912909
-
Alzheimer's disease: Beta-amyloid plaque formation in human brain
-
10.1002/syn.20957 21633975
-
Alzheimer's disease: beta-amyloid plaque formation in human brain. Seeman P, Seeman N, Synapse 2011 65 1289 1297 10.1002/syn.20957 21633975
-
(2011)
Synapse
, vol.65
, pp. 1289-1297
-
-
Seeman, P.1
Seeman, N.2
-
15
-
-
78651269012
-
Aβ40 oligomers identified as a potential biomarker for the diagnosis of alzheimer's disease
-
10.1371/journal.pone.0015725 21209907
-
Aβ40 oligomers identified as a potential biomarker for the diagnosis of alzheimer's disease. Gao CM, Yam AY, Wang X, Magdangal E, Salisbury C, Peretz D, Zuckermann RN, Connolly MD, Hansson O, Minthon L, Zetterberg H, Blennow K, Fedynyshyn JP, Allauzen S, PLoS ONE 2010 5 15725 10.1371/journal. pone.0015725 21209907
-
(2010)
PLoS ONE
, vol.5
, pp. 515725
-
-
Gao, C.M.1
Yam, A.Y.2
Wang, X.3
Magdangal, E.4
Salisbury, C.5
Peretz, D.6
Zuckermann, R.N.7
Connolly, M.D.8
Hansson, O.9
Minthon, L.10
Zetterberg, H.11
Blennow, K.12
Fedynyshyn, J.P.13
Allauzen, S.14
-
16
-
-
77954835300
-
High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
-
10.1096/fj.09-150359 20339023
-
High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. Fukumoto H, Tokuda T, Kasai T, Ishigami N, Hidaka H, Kondo M, Allsop D, Nakagawa M, Faseb J 2010 24 2716 2726 10.1096/fj.09-150359 20339023
-
(2010)
Faseb J
, vol.24
, pp. 2716-2726
-
-
Fukumoto, H.1
Tokuda, T.2
Kasai, T.3
Ishigami, N.4
Hidaka, H.5
Kondo, M.6
Allsop, D.7
Nakagawa, M.8
-
17
-
-
84873328025
-
Amyloid-beta oligomerization in Alzheimer dementia versus highpathology controls
-
10.1002/ana.23748 23225543
-
Amyloid-beta oligomerization in Alzheimer dementia versus highpathology controls. Esparza TJ, Zhao H, Cirrito JR, Cairns NJ, Bateman RJ, Holtzman DM, Brody DL, Ann Neurol 2013 73 104 119 10.1002/ana.23748 23225543
-
(2013)
Ann Neurol
, vol.73
, pp. 104-119
-
-
Esparza, T.J.1
Zhao, H.2
Cirrito, J.R.3
Cairns, N.J.4
Bateman, R.J.5
Holtzman, D.M.6
Brody, D.L.7
-
18
-
-
84875370865
-
New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF
-
10.1016/j.jalz.2012.11.005 23375565
-
New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF. Yang T, Hong S, O'Malley T, Sperling RA, Walsh DM, Selkoe DJ, Alzheimers Dement 2013 9 99 112 10.1016/j.jalz.2012.11.005 23375565
-
(2013)
Alzheimers Dement
, vol.9
, pp. 99-112
-
-
Yang, T.1
Hong, S.2
O'Malley, T.3
Sperling, R.A.4
Walsh, D.M.5
Selkoe, D.J.6
-
19
-
-
69449085355
-
Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding
-
10.2967/jnumed.109.064360 19690025
-
Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding. Tolboom N, van der Flier WM, Yaqub M, Boellaard R, Verwey NA, Blankenstein MA, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BNM, J Nucl Med 2009 50 1464 1470 10.2967/jnumed.109.064360 19690025
-
(2009)
J Nucl Med
, vol.50
, pp. 1464-1470
-
-
Tolboom, N.1
Van Der Flier, W.M.2
Yaqub, M.3
Boellaard, R.4
Verwey, N.A.5
Blankenstein, M.A.6
Windhorst, A.D.7
Scheltens, P.8
Lammertsma, A.A.9
Van Berckel, B.N.M.10
-
20
-
-
79952740168
-
Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ Amyloid
-
10.1016/j.jalz.2010.08.230 21282074
-
Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ amyloid. Weigand SD, Vemuri P, Wiste HJ, Senjem ML, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS, Jack CR Jr, Alzheimer's Disease Neuroimaging Initiative, Alzheimers Dement 2011 7 133 141 10.1016/j.jalz.2010. 08.230 21282074
-
(2011)
Alzheimers Dement
, vol.7
, pp. 133-141
-
-
Weigand, S.D.1
Vemuri, P.2
Wiste, H.J.3
Senjem, M.L.4
Pankratz, V.S.5
Aisen, P.S.6
Weiner, M.W.7
Petersen, R.C.8
Shaw, L.M.9
Trojanowski, J.Q.10
Knopman, D.S.11
Jack Jr., C.R.12
Disease Neuroimaging Initiative, A.13
-
21
-
-
64849103956
-
Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members
-
10.1093/brain/awn352 19158106
-
Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R, Bisceglio G, Rovelet-Lecrux A, Boeve B, Petersen RC, Dickson DW, Younkin SG, Deramecourt V, Crook J, Graff-Radford NR, Rademakers R, Brain 2009 132 583 591 10.1093/brain/awn352 19158106
-
(2009)
Brain
, vol.132
, pp. 583-591
-
-
Finch, N.1
Baker, M.2
Crook, R.3
Swanson, K.4
Kuntz, K.5
Surtees, R.6
Bisceglio, G.7
Rovelet-Lecrux, A.8
Boeve, B.9
Petersen, R.C.10
Dickson, D.W.11
Younkin, S.G.12
Deramecourt, V.13
Crook, J.14
Graff-Radford, N.R.15
Rademakers, R.16
-
22
-
-
79953747266
-
Plasma clusterin and the risk of Alzheimer disease
-
10.1001/jama.2011.381 21467285
-
Plasma clusterin and the risk of Alzheimer disease. Schrijvers EMC, Koudstaal PJ, Hofman A, Breteler MMB, JAMA 2011 305 1322 1326 10.1001/jama.2011.381 21467285
-
(2011)
JAMA
, vol.305
, pp. 1322-1326
-
-
Schrijvers, E.M.C.1
Koudstaal, P.J.2
Hofman, A.3
Breteler, M.M.B.4
-
23
-
-
84855759192
-
Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: A population-based study
-
21955816
-
Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study. Hansson O, Stomrud E, Vanmechelen E, Ostling S, Gustafson DR, Zetterberg H, Blennow K, Skoog I, J Alzheimers Dis 2012 28 231 238 21955816
-
(2012)
J Alzheimers Dis
, vol.28
, pp. 231-238
-
-
Hansson, O.1
Stomrud, E.2
Vanmechelen, E.3
Ostling, S.4
Gustafson, D.R.5
Zetterberg, H.6
Blennow, K.7
Skoog, I.8
-
24
-
-
77952548703
-
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
-
10.1016/j.expneurol.2009.07.024 19664622
-
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: a multicenter study with multiplexing. Lewczuk P, Kornhuber J, Vanmechelen E, Peters O, Heuser I, Maier W, Jessen F, Bürger K, Hampel H, Frolich L, Frölich L, Henn F, Falkai P, Rüther E, Jahn H, Luckhaus Ch, Perneczky R, Schmidtke K, Schröder J, Kessler H, Pantel J, Gertz HJ, Vanderstichele H, de Meyer G, Shapiro F, Wolf S, Bibl M, Wiltfang J, Exp Neurol 2010 223 366 370 10.1016/j.expneurol.2009.07.024 19664622
-
(2010)
Exp Neurol
, vol.223
, pp. 366-370
-
-
Lewczuk, P.1
Kornhuber, J.2
Vanmechelen, E.3
Peters, O.4
Heuser, I.5
Maier, W.6
Jessen, F.7
Bürger, K.8
Hampel, H.9
Frolich, L.10
Frölich, L.11
Henn, F.12
Falkai, P.13
Rüther, E.14
Jahn, H.15
Luckhaus, C.16
Perneczky, R.17
Schmidtke, K.18
Schröder, J.19
Kessler, H.20
Pantel, J.21
Gertz, H.J.22
Vanderstichele, H.23
De Meyer, G.24
Shapiro, F.25
Wolf, S.26
Bibl, M.27
Wiltfang, J.28
more..
-
25
-
-
47549117283
-
Biochemical markers in persons with preclinical familial Alzheimer disease
-
10.1212/01.wnl.0000303973.71803.81 18509095
-
Biochemical markers in persons with preclinical familial Alzheimer disease. Ringman JM, Younkin SG, Pratico D, Seltzer W, Cole GM, Geschwind DH, Rodriguez-Agudelo Y, Schaffer B, Fein J, Sokolow S, Rosario ER, Gylys KH, Varpetian A, Medina LD, Cummings JL, Neurology 2008 71 85 92 10.1212/01.wnl.0000303973.71803.81 18509095
-
(2008)
Neurology
, vol.71
, pp. 85-92
-
-
Ringman, J.M.1
Younkin, S.G.2
Pratico, D.3
Seltzer, W.4
Cole, G.M.5
Geschwind, D.H.6
Rodriguez-Agudelo, Y.7
Schaffer, B.8
Fein, J.9
Sokolow, S.10
Rosario, E.R.11
Gylys, K.H.12
Varpetian, A.13
Medina, L.D.14
Cummings, J.L.15
-
26
-
-
34447275455
-
42 levels, incident dementia, and mortality in Down syndrome
-
DOI 10.1001/archneur.64.7.1007
-
Elevated plasma beta-amyloid peptide Aβ(42) levels, incident dementia, and mortality in Down syndrome. Schupf N, Patel B, Pang D, Zigman WB, Silverman W, Mehta PD, Mayeux R, Arch Neurol 2007 64 1007 1013 10.1001/archneur.64.7.1007 17620492 (Pubitemid 47048002)
-
(2007)
Archives of Neurology
, vol.64
, Issue.7
, pp. 1007-1013
-
-
Schupf, N.1
Patel, B.2
Pang, D.3
Zigman, W.B.4
Silverman, W.5
Mehta, P.D.6
Mayeux, R.7
-
27
-
-
33746291599
-
Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment
-
DOI 10.1016/j.neurobiolaging.2006.03.004, PII S0197458006000893
-
Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment. Pesaresi M, Lovati C, Bertora P, Mailland E, Galimberti D, Scarpini E, Quadri P, Forloni G, Mariani C, Neurobiol Aging 2006 27 904 905 10.1016/j.neurobiolaging.2006.03.004 16638622 (Pubitemid 44287903)
-
(2006)
Neurobiology of Aging
, vol.27
, Issue.6
, pp. 904-905
-
-
Pesaresi, M.1
Lovati, C.2
Bertora, P.3
Mailland, E.4
Galimberti, D.5
Scarpini, E.6
Quadri, P.7
Forloni, G.8
Mariani, C.9
-
28
-
-
74149089257
-
Evaluation of plasma Aβ(40) and Aβ(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
-
10.1016/j.neurobiolaging.2008.03.027 18486992
-
Evaluation of plasma Aβ(40) and Aβ(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Hansson O, Zetterberg H, Vanmechelen E, Vanderstichele H, Andreasson U, Londos E, Wallin A, Minthon L, Blennow K, Neurobiol Aging 2010 31 357 367 10.1016/j.neurobiolaging.2008.03.027 18486992
-
(2010)
Neurobiol Aging
, vol.31
, pp. 357-367
-
-
Hansson, O.1
Zetterberg, H.2
Vanmechelen, E.3
Vanderstichele, H.4
Andreasson, U.5
Londos, E.6
Wallin, A.7
Minthon, L.8
Blennow, K.9
-
29
-
-
84863800460
-
Plasma amyloid-β as a predictor of dementia and cognitive decline: A systematic review and meta-analysis
-
10.1001/archneurol.2011.1841 22451159
-
Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis. Koyama A, Okereke OI, Yang T, Blacker D, Selkoe DJ, Grodstein F, Arch Neurol 2012 69 824 831 10.1001/archneurol.2011.1841 22451159
-
(2012)
Arch Neurol
, vol.69
, pp. 824-831
-
-
Koyama, A.1
Okereke, O.I.2
Yang, T.3
Blacker, D.4
Selkoe, D.J.5
Grodstein, F.6
-
30
-
-
84873975872
-
Biomarkers for Alzheimer's disease in plasma, serum and blood-conceptual and practical problems
-
10.1186/alzrt155 23302773
-
Biomarkers for Alzheimer's disease in plasma, serum and blood-conceptual and practical problems. Galasko D, Golde TE, Alzheimers Res Ther 2013 5 1 5 10.1186/alzrt155 23302773
-
(2013)
Alzheimers Res Ther
, vol.5
, pp. 1-5
-
-
Galasko, D.1
Golde, T.E.2
-
31
-
-
0008538685
-
A protein factor essential for microtubule assembly
-
10.1073/pnas.72.5.1858 1057175
-
A protein factor essential for microtubule assembly. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW, Proc Natl Acad Sci USA 1975 72 1858 1862 10.1073/pnas.72.5.1858 1057175
-
(1975)
Proc Natl Acad Sci USA
, vol.72
, pp. 1858-1862
-
-
Weingarten, M.D.1
Lockwood, A.H.2
Hwo, S.Y.3
Kirschner, M.W.4
-
33
-
-
67651204382
-
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
-
10.1001/jama.2009.1064 19622817
-
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka S-K, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K, JAMA 2009 302 385 393 10.1001/jama.2009.1064 19622817
-
(2009)
JAMA
, vol.302
, pp. 385-393
-
-
Mattsson, N.1
Zetterberg, H.2
Hansson, O.3
Andreasen, N.4
Parnetti, L.5
Jonsson, M.6
Herukka, S.-K.7
Van Der Flier, W.M.8
Blankenstein, M.A.9
Ewers, M.10
Rich, K.11
Kaiser, E.12
Verbeek, M.13
Tsolaki, M.14
Mulugeta, E.15
Rosén, E.16
Aarsland, D.17
Visser, P.J.18
Schröder, J.19
Marcusson, J.20
De Leon, M.21
Hampel, H.22
Scheltens, P.23
Pirttilä, T.24
Wallin, A.25
Jönhagen, M.E.26
Minthon, L.27
Winblad, B.28
Blennow, K.29
more..
-
34
-
-
74949097405
-
Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization
-
10.1212/WNL.0b013e3181cb3e25 20042704
-
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, Jack CR, Jagust WJ, Shaw LM, Toga AW, Trojanowski JQ, Weiner MW, Neurology 2010 74 201 209 10.1212/WNL.0b013e3181cb3e25 20042704
-
(2010)
Neurology
, vol.74
, pp. 201-209
-
-
Petersen, R.C.1
Aisen, P.S.2
Beckett, L.A.3
Donohue, M.C.4
Gamst, A.C.5
Harvey, D.J.6
Jack, C.R.7
Jagust, W.J.8
Shaw, L.M.9
Toga, A.W.10
Trojanowski, J.Q.11
Weiner, M.W.12
-
35
-
-
33748628239
-
Neurochemical aftermath of amateur boxing
-
DOI 10.1001/archneur.63.9.1277
-
Neurochemical aftermath of amateur boxing. Zetterberg H, Hietala MA, Jonsson M, Andreasen N, Styrud E, Karlsson I, Edman A, Popa C, Rasulzada A, Wahlund LO, Mehta PD, Rosengren L, Blennow K, Wallin A, Arch Neurol 2006 63 1277 1280 10.1001/archneur.63.9.1277 16966505 (Pubitemid 44379829)
-
(2006)
Archives of Neurology
, vol.63
, Issue.9
, pp. 1277-1280
-
-
Zetterberg, H.1
Hietala, M.A.2
Jonsson, M.3
Andreasen, N.4
Styrud, E.5
Karlsson, I.6
Edman, A.7
Popa, C.8
Rasulzada, A.9
Wahlund, L.-O.10
Mehta, P.D.11
Rosengren, L.12
Blennow, K.13
Wallin, A.14
-
36
-
-
33750999347
-
Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury
-
DOI 10.1212/01.wnl.0000242732.06714.0f, PII 0000611420061114000016
-
Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Ost M, Nylen K, Csajbok L, Ohrfelt AO, Tullberg M, Wikkelso C, Nellgard P, Rosengren L, Blennow K, Nellgard B, Neurology 2006 67 1600 1604 10.1212/01.wnl.0000242732.06714.0f 17101890 (Pubitemid 44747930)
-
(2006)
Neurology
, vol.67
, Issue.9
, pp. 1600-1604
-
-
Ost, M.1
Nylen, K.2
Csajbok, L.3
Ohrfelt, A.O.4
Tullberg, M.5
Wikkelso, C.6
Nellgard, P.7
Rosengren, L.8
Blennow, K.9
Nellgard, B.10
-
37
-
-
0035910638
-
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
-
DOI 10.1016/S0304-3940(00)01697-9, PII S0304394000016979
-
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Hesse C, Rosengren L, Andreasen N, Davidsson P, Vanderstichele H, Vanmechelen E, Blennow K, Neurosci Lett 2001 297 187 190 10.1016/S0304-3940(00)01697-9 11137759 (Pubitemid 32011305)
-
(2001)
Neuroscience Letters
, vol.297
, Issue.3
, pp. 187-190
-
-
Hesse, C.1
Rosengren, L.2
Andreasen, N.3
Davidsson, P.4
Vanderstichele, H.5
Vanmechelen, E.6
Blennow, K.7
-
38
-
-
0031951155
-
CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease
-
CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease. Tapiola T, Lehtovirta M, Ramberg J, Helisalmi S, Linnaranta K, Riekkinen P, Soininen H, Neurology 1998 50 169 174 10.1212/WNL.50.1.169 9443475 (Pubitemid 28106037)
-
(1998)
Neurology
, vol.50
, Issue.1
, pp. 169-174
-
-
Tapiola, T.1
Lehtovirta, M.2
Ramberg, J.3
Helisalmi, S.4
Linnaranta, K.5
Riekkinen Sr., P.6
Soininen, H.7
-
39
-
-
0035108753
-
Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
-
Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice. Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K, Arch Neurol 2001 58 373 379 10.1001/archneur.58.3.373 11255440 (Pubitemid 32217453)
-
(2001)
Archives of Neurology
, vol.58
, Issue.3
, pp. 373-379
-
-
Andreasen, N.1
Minthon, L.2
Davidsson, P.3
Vanmechelen, E.4
Vanderstichele, H.5
Winblad, B.6
Blennow, K.7
-
40
-
-
77949423619
-
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
-
10.1038/nrneurol.2010.4 20157306
-
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Blennow K, Hampel H, Weiner M, Zetterberg H, Nat Rev Neurol 2010 6 131 144 10.1038/nrneurol.2010.4 20157306
-
(2010)
Nat Rev Neurol
, vol.6
, pp. 131-144
-
-
Blennow, K.1
Hampel, H.2
Weiner, M.3
Zetterberg, H.4
-
41
-
-
85022868612
-
4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia
-
4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia. Gauthier S, Patterson C, Chertkow H, Gordon M, Herrmann N, Rockwood K, Rosa-Neto P, Soucy JP, CCCDTD4 participants, Can J Neurol Sci 2012 39 6 Suppl 5 1 S8
-
(2012)
Can J Neurol Sci
, vol.39
, Issue.SUPPL. 5
-
-
Gauthier, S.1
Patterson, C.2
Chertkow, H.3
Gordon, M.4
Herrmann, N.5
Rockwood, K.6
Rosa-Neto, P.7
Soucy, J.P.8
Participants, C.9
-
42
-
-
84938295812
-
Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)
-
23259025
-
Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4). Gauthier S, Patterson C, Chertkow H, Gordon M, Herrmann N, Rockwood K, Rosa-Neto P, Soucy J-P, Can Geriatr J 2012 15 120 126 23259025
-
(2012)
Can Geriatr J
, vol.15
, pp. 120-126
-
-
Gauthier, S.1
Patterson, C.2
Chertkow, H.3
Gordon, M.4
Herrmann, N.5
Rockwood, K.6
Rosa-Neto, P.7
Soucy, J.-P.8
-
43
-
-
43049113533
-
Rating quality of evidence and strength of recommendations: GRADE: An emerging consensus on rating quality of evidence and strength of recommendations
-
10.1136/bmj.39489.470347.AD 18436948
-
Rating quality of evidence and strength of recommendations: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ, BMJ 2008 336 924 10.1136/bmj.39489.470347. AD 18436948
-
(2008)
BMJ
, vol.336
, pp. 924
-
-
Guyatt, G.H.1
Oxman, A.D.2
Vist, G.E.3
Kunz, R.4
Falck-Ytter, Y.5
Alonso-Coello, P.6
Schünemann, H.J.7
-
44
-
-
73449137232
-
Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe
-
10.1111/j.1468-1331.2009.02753.x 19659752
-
Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe. Hort J, Bartos A, Pirttila T, Scheltens P, Eur J Neurol 2010 17 90 96 10.1111/j.1468-1331.2009.02753.x 19659752
-
(2010)
Eur J Neurol
, vol.17
, pp. 90-96
-
-
Hort, J.1
Bartos, A.2
Pirttila, T.3
Scheltens, P.4
-
45
-
-
84862128944
-
Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease
-
10.1016/j.ymeth.2012.03.023 22503777
-
Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease. Kang J-H, Vanderstichele H, Trojanowski JQ, Shaw LM, Methods 2012 56 484 493 10.1016/j.ymeth.2012.03.023 22503777
-
(2012)
Methods
, vol.56
, pp. 484-493
-
-
Kang, J.-H.1
Vanderstichele, H.2
Trojanowski, J.Q.3
Shaw, L.M.4
-
46
-
-
84856008210
-
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
-
10.1016/j.jalz.2011.07.004 22047631
-
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, Parnetti L, Perret-Liaudet A, Shaw LM, Teunissen C, Wouters D, Blennow K, Alzheimers Dement 2012 8 65 73 10.1016/j.jalz.2011.07.004 22047631
-
(2012)
Alzheimers Dement
, vol.8
, pp. 65-73
-
-
Vanderstichele, H.1
Bibl, M.2
Engelborghs, S.3
Le Bastard, N.4
Lewczuk, P.5
Molinuevo, J.L.6
Parnetti, L.7
Perret-Liaudet, A.8
Shaw, L.M.9
Teunissen, C.10
Wouters, D.11
Blennow, K.12
-
48
-
-
33745920161
-
Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
-
DOI 10.1038/nm1438, PII NM1438
-
Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM, Nat Med 2006 12 856 861 10.1038/nm1438 16799555 (Pubitemid 44050079)
-
(2006)
Nature Medicine
, vol.12
, Issue.7
, pp. 856-861
-
-
Bateman, R.J.1
Munsell, L.Y.2
Morris, J.C.3
Swarm, R.4
Yarasheski, K.E.5
Holtzman, D.M.6
-
49
-
-
77955483685
-
Alzheimer's Disease Neuroimaging Initiative: Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects
-
10.1016/j.jalz.2010.03.008 20451871
-
Alzheimer's Disease Neuroimaging Initiative: Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR Jr, Jagust W, Toga AW, Lee VM, Shaw LM, Alzheimers Dement 2010 6 230 238 10.1016/j.jalz.2010.03.008 20451871
-
(2010)
Alzheimers Dement
, vol.6
, pp. 230-238
-
-
Trojanowski, J.Q.1
Vandeerstichele, H.2
Korecka, M.3
Clark, C.M.4
Aisen, P.S.5
Petersen, R.C.6
Blennow, K.7
Soares, H.8
Simon, A.9
Lewczuk, P.10
Dean, R.11
Siemers, E.12
Potter, W.Z.13
Weiner, M.W.14
Jack Jr., C.R.15
Jagust, W.16
Toga, A.W.17
Lee, V.M.18
Shaw, L.M.19
-
50
-
-
77954623809
-
Alzheimer's Disease Neuroimaging Initiative: Update on the magnetic resonance imaging core of the Alzheimer's Disease Neuroimaging Initiative
-
10.1016/j.jalz.2010.03.004 20451869
-
Alzheimer's Disease Neuroimaging Initiative: Update on the magnetic resonance imaging core of the Alzheimer's Disease Neuroimaging Initiative. Jack CR Jr, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM, Schuff N, Krueger G, Killiany RJ, DeCarli CS, Dale AM, Carmichael OW, Tosun D, Weiner MW, Alzheimers Dement 2010 6 212 220 10.1016/j.jalz.2010.03.004 20451869
-
(2010)
Alzheimers Dement
, vol.6
, pp. 212-220
-
-
Jack Jr., C.R.1
Bernstein, M.A.2
Borowski, B.J.3
Gunter, J.L.4
Fox, N.C.5
Thompson, P.M.6
Schuff, N.7
Krueger, G.8
Killiany, R.J.9
Decarli, C.S.10
Dale, A.M.11
Carmichael, O.W.12
Tosun, D.13
Weiner, M.W.14
-
51
-
-
9144257234
-
Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosis of Alzheimer Disease: A Comparative Cerebrospinal Fluid Study
-
DOI 10.1001/archpsyc.61.1.95
-
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, Sjoegren M, DeBernardis J, Kerkman D, Ishiguro K, Ohno H, Vanmechelen E, Vanderstichele H, McCulloch C, Moller HJ, Davies P, Blennow K, Arch Gen Psychiatry 2004 61 95 102 10.1001/archpsyc.61.1.95 14706948 (Pubitemid 38044645)
-
(2004)
Archives of General Psychiatry
, vol.61
, Issue.1
, pp. 95-102
-
-
Hampel, H.1
Buerger, K.2
Zinkowski, R.3
Teipel, S.J.4
Goernitz, A.5
Andreasen, N.6
Sjoegren, M.7
DeBernardis, J.8
Kerkman, D.9
Ishiguro, K.10
Ohno, H.11
Vanmechelen, E.12
Vanderstichele, H.13
McCulloch, C.14
Moller, H.-J.15
Davies, P.16
Blennow, K.17
-
52
-
-
79959699255
-
Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease
-
10.1093/brain/awr130 21705422
-
Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease. de Souza LC, Corlier F, Habert MO, Uspenskaya O, Maroy R, Lamari F, Chupin M, Lehéricy S, Colliot O, Hahn-Barma V, Samri D, Dubois B, Bottlaender M, Sarazin M, Brain 2011 134 2036 2043 10.1093/brain/awr130 21705422
-
(2011)
Brain
, vol.134
, pp. 2036-2043
-
-
De Souza, L.C.1
Corlier, F.2
Habert, M.O.3
Uspenskaya, O.4
Maroy, R.5
Lamari, F.6
Chupin, M.7
Lehéricy, S.8
Colliot, O.9
Hahn-Barma, V.10
Samri, D.11
Dubois, B.12
Bottlaender, M.13
Sarazin, M.14
-
53
-
-
62449262536
-
Cerebrospinal fluid beta-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
-
10.1001/archneurol.2008.596 19273758
-
Cerebrospinal fluid beta-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Tapiola T, Alafuzoff I, Herukka S-K, Parkkinen L, Hartikainen P, Soininen H, Pirttila T, Arch Neurol 2009 66 382 389 10.1001/archneurol.2008.596 19273758
-
(2009)
Arch Neurol
, vol.66
, pp. 382-389
-
-
Tapiola, T.1
Alafuzoff, I.2
Herukka, S.-K.3
Parkkinen, L.4
Hartikainen, P.5
Soininen, H.6
Pirttila, T.7
-
54
-
-
77956935120
-
Added diagnostic value of CSF biomarkers in differential dementia diagnosis
-
10.1016/j.neurobiolaging.2008.10.017 19150153
-
Added diagnostic value of CSF biomarkers in differential dementia diagnosis. Bastard NL, Martin J-J, Vanmechelen E, Vanderstichele H, Deyn PPD, Engelborghs S, Neurobiol Aging 2010 31 1867 1876 10.1016/j.neurobiolaging.2008. 10.017 19150153
-
(2010)
Neurobiol Aging
, vol.31
, pp. 1867-1876
-
-
Bastard, N.L.1
Martin, J.-J.2
Vanmechelen, E.3
Vanderstichele, H.4
Deyn, P.P.D.5
Engelborghs, S.6
-
55
-
-
70350532722
-
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
-
10.1212/WNL.0b013e3181bd8271 19858456
-
CSF biomarkers predict rate of cognitive decline in Alzheimer disease. Kester MI, van der Vlies AE, Blankenstein MA, Pijnenburg YAL, van Elk EJ, Scheltens P, van der Flier WM, Neurology 2009 73 1353 1358 10.1212/WNL. 0b013e3181bd8271 19858456
-
(2009)
Neurology
, vol.73
, pp. 1353-1358
-
-
Kester, M.I.1
Van Der Vlies, A.E.2
Blankenstein, M.A.3
Pijnenburg, Y.A.L.4
Van Elk, E.J.5
Scheltens, P.6
Van Der Flier, W.M.7
-
56
-
-
84856617005
-
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
-
22170879
-
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Schoonenboom NSM, Reesink FE, Verwey NA, Kester MI, Teunissen CE, van de Ven PM, Pijnenburg YAL, Blankenstein MA, Rozemuller AJ, Scheltens P, van der Flier WM, Neurology 2011 78 47 54 22170879
-
(2011)
Neurology
, vol.78
, pp. 47-54
-
-
Schoonenboom, N.S.M.1
Reesink, F.E.2
Verwey, N.A.3
Kester, M.I.4
Teunissen, C.E.5
Van De Ven, P.M.6
Pijnenburg, Y.A.L.7
Blankenstein, M.A.8
Rozemuller, A.J.9
Scheltens, P.10
Van Der Flier, W.M.11
-
57
-
-
32544435900
-
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study
-
DOI 10.1016/S1474-4422(06)70355-6, PII S1474442206703556
-
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L, Lancet Neurol 2006 5 228 234 10.1016/S1474-4422(06)70355-6 16488378 (Pubitemid 43238346)
-
(2006)
Lancet Neurology
, vol.5
, Issue.3
, pp. 228-234
-
-
Hansson, O.1
Zetterberg, H.2
Buchhave, P.3
Londos, E.4
Blennow, K.5
Minthon, L.6
-
58
-
-
0037837209
-
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias
-
DOI 10.1038/sj.mp.4001220
-
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Riemenschneider M, Wagenpfeil S, Vanderstichele H, Otto M, Wiltfang J, Kretzschmar H, Vanmechelen E, Förstl H, Kurz A, Mol Psychiatry 2003 8 343 347 10.1038/sj.mp.4001220 12660807 (Pubitemid 36712928)
-
(2003)
Molecular Psychiatry
, vol.8
, Issue.3
, pp. 343-347
-
-
Riemenschneider, M.1
Wagenpfeil, S.2
Vanderstichele, H.3
Otto, M.4
Wiltfang, J.5
Kretzschmar, H.6
Vanmechelen, E.7
Forstl, H.8
Kurz, A.9
-
59
-
-
82755161905
-
Biomarkers for Alzheimer's disease therapeutic trials
-
10.1016/j.pneurobio.2010.11.005 21130138
-
Biomarkers for Alzheimer's disease therapeutic trials. Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B, Oxford Task Force Group, Prog Neurobiol 2011 95 579 593 10.1016/j.pneurobio.2010.11.005 21130138
-
(2011)
Prog Neurobiol
, vol.95
, pp. 579-593
-
-
Hampel, H.1
Wilcock, G.2
Andrieu, S.3
Aisen, P.4
Blennow, K.5
Broich, K.6
Carrillo, M.7
Fox, N.C.8
Frisoni, G.B.9
Isaac, M.10
Lovestone, S.11
Nordberg, A.12
Prvulovic, D.13
Sampaio, C.14
Scheltens, P.15
Weiner, M.16
Winblad, B.17
Coley, N.18
Vellas, B.19
Task Force Group, O.20
more..
-
60
-
-
77954555375
-
Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: Implications for trial design
-
Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design. van Rossum IA, Vos S, Handels R, Visser PJ, J Alzheimers Disease 2010 20 881 891
-
(2010)
J Alzheimers Disease
, vol.20
, pp. 881-891
-
-
Van Rossum, I.A.1
Vos, S.2
Handels, R.3
Visser, P.J.4
-
61
-
-
78650464378
-
Evaluation of CSF biomarkers as predictors of Alzheimer's disease: A clinical follow-up study of 4.7 years
-
21504133
-
Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years. Hertze J, Minthon L, Zetterberg H, Vanmechelen E, Blennow K, Hansson O, J Alzheimers Dis 2010 21 1119 1128 21504133
-
(2010)
J Alzheimers Dis
, vol.21
, pp. 1119-1128
-
-
Hertze, J.1
Minthon, L.2
Zetterberg, H.3
Vanmechelen, E.4
Blennow, K.5
Hansson, O.6
-
62
-
-
65449157673
-
Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype
-
10.1159/000216841 19420940
-
Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype. Blom ES, Giedraitis V, Zetterberg H, Fukumoto H, Blennow K, Hyman BT, Irizarry MC, Wahlund L-O, Lannfelt L, Ingelsson M, Dement Geriatr Cogn Disord 2009 27 458 464 10.1159/000216841 19420940
-
(2009)
Dement Geriatr Cogn Disord
, vol.27
, pp. 458-464
-
-
Blom, E.S.1
Giedraitis, V.2
Zetterberg, H.3
Fukumoto, H.4
Blennow, K.5
Hyman, B.T.6
Irizarry, M.C.7
Wahlund, L.-O.8
Lannfelt, L.9
Ingelsson, M.10
-
63
-
-
77954028812
-
Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment
-
1451.e1 10.1016/j.neurobiolaging.2010.04.036 20541287
-
Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment. Lorenzi M, Donohue M, Paternicò D, Scarpazza C, Ostrowitzki S, Blin O, Irving E, Frisoni GB, Alzheimer's Disease Neuroimaging Initiative, Neurobiol Aging 2010 31 1443 1451 1451.e1 10.1016/j.neurobiolaging.2010.04.036 20541287
-
(2010)
Neurobiol Aging
, vol.31
, pp. 1443-1451
-
-
Lorenzi, M.1
Donohue, M.2
Paternicò, D.3
Scarpazza, C.4
Ostrowitzki, S.5
Blin, O.6
Irving, E.7
Frisoni, G.B.8
Disease Neuroimaging Initiative, A.9
-
64
-
-
0037244487
-
Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment
-
DOI 10.1034/j.1600-0404.107.s179.9.x
-
Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment. Andreasen N, Vanmechelen E, Vanderstichele H, Davidsson P, Blennow K, Acta Neurol Scand 2003 107 47 51 10.1034/j.1600-0404.107.s179.9.x (Pubitemid 41737337)
-
(2003)
Acta Neurologica Scandinavica
, vol.107
, Issue.SUPPL. 179
, pp. 47-51
-
-
Andreasen, N.1
Vanmechelen, E.2
Vanderstichele, H.3
Davidsson, P.4
Blennow, K.5
-
65
-
-
77955453909
-
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people
-
10.1001/archneurol.2010.179 20697045
-
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. De Meyer G, Shapiro F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, Blennow K, Shaw L, Trojanowski JQ, Alzheimer's Disease Neuroimaging Initiative, Arch Neurol 2010 67 949 956 10.1001/archneurol.2010.179 20697045
-
(2010)
Arch Neurol
, vol.67
, pp. 949-956
-
-
De Meyer, G.1
Shapiro, F.2
Vanderstichele, H.3
Vanmechelen, E.4
Engelborghs, S.5
De Deyn, P.P.6
Coart, E.7
Hansson, O.8
Minthon, L.9
Zetterberg, H.10
Blennow, K.11
Shaw, L.12
Trojanowski, J.Q.13
Disease Neuroimaging Initiative, A.14
-
66
-
-
49149128686
-
Increasing CSF phospho-tau levels during cognitive decline and progression to dementia
-
10.1016/j.neurobiolaging.2007.03.027 17512092
-
Increasing CSF phospho-tau levels during cognitive decline and progression to dementia. Andersson C, Blennow K, Almkvist O, Andreasen N, Engfeldt P, Johansson S-E, Lindau M, Eriksdotter-Jonhagen M, Neurobiol Aging 2008 29 1466 1473 10.1016/j.neurobiolaging.2007.03.027 17512092
-
(2008)
Neurobiol Aging
, vol.29
, pp. 1466-1473
-
-
Andersson, C.1
Blennow, K.2
Almkvist, O.3
Andreasen, N.4
Engfeldt, P.5
Johansson, S.-E.6
Lindau, M.7
Eriksdotter-Jonhagen, M.8
-
67
-
-
77954030909
-
Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: A longitudinal MRI study
-
10.1016/j.neurobiolaging.2010.04.030 20570401
-
Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study. Tosun D, Schuff N, Truran-Sacrey D, Shaw LM, Trojanowski JQ, Aisen P, Peterson R, Weiner MW, Alzheimer's Disease Neuroimaging Initiative, Neurobiol Aging 2010 31 1340 1354 10.1016/j. neurobiolaging.2010.04.030 20570401
-
(2010)
Neurobiol Aging
, vol.31
, pp. 1340-1354
-
-
Tosun, D.1
Schuff, N.2
Truran-Sacrey, D.3
Shaw, L.M.4
Trojanowski, J.Q.5
Aisen, P.6
Peterson, R.7
Weiner, M.W.8
Disease Neuroimaging Initiative, A.9
-
68
-
-
70349884191
-
CSF biomarker levels in early and late onset Alzheimer's disease
-
10.1016/j.neurobiolaging.2008.02.007 18403055
-
CSF biomarker levels in early and late onset Alzheimer's disease. Bouwman FH, Schoonenboom NSM, Verwey NA, van Elk EJ, Kok A, Blankenstein MA, Scheltens P, van der Flier WM, Neurobiol Aging 2009 30 1895 1901 10.1016/j.neurobiolaging. 2008.02.007 18403055
-
(2009)
Neurobiol Aging
, vol.30
, pp. 1895-1901
-
-
Bouwman, F.H.1
Schoonenboom, N.S.M.2
Verwey, N.A.3
Van Elk, E.J.4
Kok, A.5
Blankenstein, M.A.6
Scheltens, P.7
Van Der Flier, W.M.8
-
69
-
-
67650348317
-
CSF biomarkers in relationship to cognitive profiles in Alzheimer disease
-
10.1212/01.wnl.0000345014.48839.71 19307538
-
CSF biomarkers in relationship to cognitive profiles in Alzheimer disease. van der Vlies AE, Verwey NA, Bouwman FH, Blankenstein MA, Klein M, Scheltens P, van der Flier WM, Neurology 2009 72 1056 1061 10.1212/01.wnl. 0000345014.48839.71 19307538
-
(2009)
Neurology
, vol.72
, pp. 1056-1061
-
-
Van Der Vlies, A.E.1
Verwey, N.A.2
Bouwman, F.H.3
Blankenstein, M.A.4
Klein, M.5
Scheltens, P.6
Van Der Flier, W.M.7
-
70
-
-
77950538544
-
Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study
-
10.1016/j.neurobiolaging.2008.06.016 18692273
-
Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study. Sluimer JD, Bouwman FH, Vrenken H, Blankenstein MA, Barkhof F, van der Flier WM, Scheltens P, Neurobiol Aging 2010 31 758 764 10.1016/j.neurobiolaging.2008.06.016 18692273
-
(2010)
Neurobiol Aging
, vol.31
, pp. 758-764
-
-
Sluimer, J.D.1
Bouwman, F.H.2
Vrenken, H.3
Blankenstein, M.A.4
Barkhof, F.5
Van Der Flier, W.M.6
Scheltens, P.7
-
71
-
-
76649123574
-
CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease
-
10.1523/JNEUROSCI.3785-09.2010 20147537
-
CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM, Alzheimer's Disease Neuroimaging Initiative, J Neurosci 2010 30 2088 2101 10.1523/JNEUROSCI.3785-09.2010 20147537
-
(2010)
J Neurosci
, vol.30
, pp. 2088-2101
-
-
Fjell, A.M.1
Walhovd, K.B.2
Fennema-Notestine, C.3
McEvoy, L.K.4
Hagler, D.J.5
Holland, D.6
Brewer, J.B.7
Dale, A.M.8
Disease Neuroimaging Initiative, A.9
-
72
-
-
67349165107
-
Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease
-
10.1007/s00259-009-1063-7 19219430
-
Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease. Arlt S, Brassen S, Jahn H, Wilke F, Eichenlaub M, Apostolova I, Wenzel F, Thiele F, Young S, Buchert R, Eur J Nucl Med Mol Imaging 2009 36 1090 1100 10.1007/s00259-009-1063-7 19219430
-
(2009)
Eur J Nucl Med Mol Imaging
, vol.36
, pp. 1090-1100
-
-
Arlt, S.1
Brassen, S.2
Jahn, H.3
Wilke, F.4
Eichenlaub, M.5
Apostolova, I.6
Wenzel, F.7
Thiele, F.8
Young, S.9
Buchert, R.10
-
73
-
-
68249111164
-
MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change
-
10.1212/WNL.0b013e3181af79fb 19636049
-
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr, Alzheimer's Disease Neuroimaging Initiative, Neurology 2009 73 294 301 10.1212/WNL.0b013e3181af79fb 19636049
-
(2009)
Neurology
, vol.73
, pp. 294-301
-
-
Vemuri, P.1
Wiste, H.J.2
Weigand, S.D.3
Shaw, L.M.4
Trojanowski, J.Q.5
Weiner, M.W.6
Knopman, D.S.7
Petersen, R.C.8
Jack Jr., C.R.9
Disease Neuroimaging Initiative, A.10
-
74
-
-
80052846251
-
Longitudinal changes of CSF biomarkers in Alzheimer's disease
-
Longitudinal changes of CSF biomarkers in Alzheimer's disease. Seppälä TT, Koivisto AM, Hartikainen P, Helisalmi S, Soininen H, Herukka S-K, J Alzheimers Disease 2011 25 583 594
-
(2011)
J Alzheimers Disease
, vol.25
, pp. 583-594
-
-
Seppälä, T.T.1
Koivisto, A.M.2
Hartikainen, P.3
Helisalmi, S.4
Soininen, H.5
Herukka, S.-K.6
-
75
-
-
79951938156
-
Combined measurement of PEDF, haptoglobin and tau in fluid improves the diagnostic discrimination between alzheimer's disease and other dementias
-
10.3109/1354750X.2010.536995 21323605
-
Combined measurement of PEDF, haptoglobin and tau in fluid improves the diagnostic discrimination between alzheimer's disease and other dementias. Abraham J-D, Calvayrac-Pawlowski S, Cobo S, Salvetat N, Vicat G, Molina L, Touchon J, Michel BF, Molina F, Verdier JM, Fareh J, Mourton-Gilles C, Biomarkers 2011 16 161 171 10.3109/1354750X.2010.536995 21323605
-
(2011)
Biomarkers
, vol.16
, pp. 161-171
-
-
Abraham, J.-D.1
Calvayrac-Pawlowski, S.2
Cobo, S.3
Salvetat, N.4
Vicat, G.5
Molina, L.6
Touchon, J.7
Michel, B.F.8
Molina, F.9
Verdier, J.M.10
Fareh, J.11
Mourton-Gilles, C.12
-
76
-
-
77955112799
-
Increased levels of soluble LR11 in cerebrospinal fluid of patients with Alzheimer disease
-
10.1159/000315539 20689279
-
Increased levels of soluble LR11 in cerebrospinal fluid of patients with Alzheimer disease. Ikeuchi T, Hirayama S, Miida T, Fukamachi I, Tokutake T, Ebinuma H, Takubo K, Kaneko H, Kasuga K, Kakita A, Takahashi H, Bujo H, Saito Y, Nishizawa M, Dement Geriatr Cogn Disord 2010 30 28 32 10.1159/000315539 20689279
-
(2010)
Dement Geriatr Cogn Disord
, vol.30
, pp. 28-32
-
-
Ikeuchi, T.1
Hirayama, S.2
Miida, T.3
Fukamachi, I.4
Tokutake, T.5
Ebinuma, H.6
Takubo, K.7
Kaneko, H.8
Kasuga, K.9
Kakita, A.10
Takahashi, H.11
Bujo, H.12
Saito, Y.13
Nishizawa, M.14
-
77
-
-
77953029039
-
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment
-
10.1007/s00401-010-0667-0 20232070
-
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment. Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, Pickering E, Kuhn M, Chen Y, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ, Acta Neuropathol 2010 119 669 678 10.1007/s00401-010-0667-0 20232070
-
(2010)
Acta Neuropathol
, vol.119
, pp. 669-678
-
-
Hu, W.T.1
Chen-Plotkin, A.2
Arnold, S.E.3
Grossman, M.4
Clark, C.M.5
Shaw, L.M.6
Pickering, E.7
Kuhn, M.8
Chen, Y.9
McCluskey, L.10
Elman, L.11
Karlawish, J.12
Hurtig, H.I.13
Siderowf, A.14
Lee, V.M.15
Soares, H.16
Trojanowski, J.Q.17
-
78
-
-
84858120121
-
Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease
-
22214781
-
Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease. Santos AN, Ewers M, Minthon L, Simm A, Silber R-E, Blennow K, Prvulovic D, Hansson O, Hampel H, J Alzheimers Dis 2012 29 171 176 22214781
-
(2012)
J Alzheimers Dis
, vol.29
, pp. 171-176
-
-
Santos, A.N.1
Ewers, M.2
Minthon, L.3
Simm, A.4
Silber, R.-E.5
Blennow, K.6
Prvulovic, D.7
Hansson, O.8
Hampel, H.9
-
79
-
-
78649712259
-
Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias
-
10.1159/000322370 21135556
-
Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias. Bibl M, Mollenhauer B, Lewczuk P, Esselmann H, Wolf S, Otto M, Kornhuber J, Rüther E, Wiltfang J, Dement Geriatr Cogn Disord 2011 31 37 44 10.1159/000322370 21135556
-
(2011)
Dement Geriatr Cogn Disord
, vol.31
, pp. 37-44
-
-
Bibl, M.1
Mollenhauer, B.2
Lewczuk, P.3
Esselmann, H.4
Wolf, S.5
Otto, M.6
Kornhuber, J.7
Rüther, E.8
Wiltfang, J.9
-
80
-
-
54449085260
-
Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration
-
10.1212/01.wnl.0000325058.10218.fc 18768919
-
Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Ghidoni R, Benussi L, Glionna M, Franzoni M, Binetti G, Neurology 2008 71 1235 1239 10.1212/01.wnl.0000325058.10218.fc 18768919
-
(2008)
Neurology
, vol.71
, pp. 1235-1239
-
-
Ghidoni, R.1
Benussi, L.2
Glionna, M.3
Franzoni, M.4
Binetti, G.5
-
81
-
-
78049420077
-
Multiple brain pathologies in dementia are common
-
10.1016/j.eurger.2010.07.012
-
Multiple brain pathologies in dementia are common. Woodward M, Mackenzie IRA, Hsiung GYR, Jacova C, Feldman H, Eur Geriatr Med 2010 1 259 265 10.1016/j.eurger.2010.07.012
-
(2010)
Eur Geriatr Med
, vol.1
, pp. 259-265
-
-
Woodward, M.1
Mackenzie, I.R.A.2
Hsiung, G.Y.R.3
Jacova, C.4
Feldman, H.5
-
82
-
-
33746641249
-
42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia
-
Cerebrospinal fluid amyloid beta42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia. de Jong D, Jansen RWMM, Kremer BPH, Verbeek MM, J Gerontol A Biol Sci Med Sci 2006 61 755 758 10.1093/gerona/61.7.755 16870640 (Pubitemid 44148364)
-
(2006)
Journals of Gerontology - Series A Biological Sciences and Medical Sciences
, vol.61
, Issue.7
, pp. 755-758
-
-
De Jong, D.1
Jansen, R.W.M.M.2
Kremer, B.P.H.3
Verbeek, M.M.4
-
83
-
-
34249040510
-
Blood-brain barrier impairment in Alzheimer disease: Stability and functional significance
-
DOI 10.1212/01.wnl.0000262031.18018.1a, PII 0000611420070522000008
-
Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF, Neurology 2007 68 1809 1814 10.1212/01.wnl.0000262031.18018.1a 17515542 (Pubitemid 46791393)
-
(2007)
Neurology
, vol.68
, Issue.21
, pp. 1809-1814
-
-
Bowman, G.L.1
Kaye, J.A.2
Moore, M.3
Waichunas, D.4
Carlson, N.E.5
Quinn, J.F.6
-
84
-
-
60549089053
-
Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants
-
10.1001/archneurol.2008.533 19204157
-
Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants. Appleby BS, Appleby KK, Crain BJ, Onyike CU, Wallin MT, Rabins PV, Arch Neurol 2009 66 208 215 10.1001/archneurol.2008.533 19204157
-
(2009)
Arch Neurol
, vol.66
, pp. 208-215
-
-
Appleby, B.S.1
Appleby, K.K.2
Crain, B.J.3
Onyike, C.U.4
Wallin, M.T.5
Rabins, P.V.6
-
85
-
-
67649386714
-
Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?
-
10.1002/gps.2195 19123199
-
Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease? Wallin ÅK, Hansson O, Blennow K, Londos E, Minthon L, Int J Geriatr Psychiatry 2009 24 638 647 10.1002/gps.2195 19123199
-
(2009)
Int J Geriatr Psychiatry
, vol.24
, pp. 638-647
-
-
Wallin, Å.1
Hansson, O.2
Blennow, K.3
Londos, E.4
Minthon, L.5
-
86
-
-
79960756506
-
Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease
-
21471645
-
Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease. Chalbot S, Zetterberg H, Blennow K, Fladby T, Andreasen N, Grundke-Iqbal I, Iqbal K, J Alzheimers Dis 2011 25 505 515 21471645
-
(2011)
J Alzheimers Dis
, vol.25
, pp. 505-515
-
-
Chalbot, S.1
Zetterberg, H.2
Blennow, K.3
Fladby, T.4
Andreasen, N.5
Grundke-Iqbal, I.6
Iqbal, K.7
-
87
-
-
0026569503
-
Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia
-
10.1111/j.1600-0404.1992.tb04006.x 1574982
-
Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia. Fredman P, Wallin A, Blennow K, Davidsson P, Gottfries CG, Svennerholm L, Acta Neurol Scand 1992 85 103 106 10.1111/j.1600-0404.1992. tb04006.x 1574982
-
(1992)
Acta Neurol Scand
, vol.85
, pp. 103-106
-
-
Fredman, P.1
Wallin, A.2
Blennow, K.3
Davidsson, P.4
Gottfries, C.G.5
Svennerholm, L.6
-
88
-
-
0034083532
-
CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy
-
DOI 10.1136/jnnp.69.1.74
-
CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy. Tullberg M, Månsson J-E, Fredman P, Lekman A, Blennow K, Ekman R, Rosengren LE, Tisell M, Wikkelso C, J Neurol Neurosurg Psychiatry 2000 69 74 81 10.1136/jnnp.69.1.74 10864607 (Pubitemid 30410418)
-
(2000)
Journal of Neurology Neurosurgery and Psychiatry
, vol.69
, Issue.1
, pp. 74-81
-
-
Tullberg, M.1
Mansson, J.-E.2
Fredman, P.3
Lekman, A.4
Blennow, K.5
Ekman, R.6
Rosengren, L.E.7
Tisell, M.8
Wikkelso, C.9
-
89
-
-
0038479920
-
Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia
-
DOI 10.1002/ana.10618
-
Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia. Han X, Fagan AM, Cheng H, Morris JC, Xiong C, Holtzman DM, Ann Neurol 2003 54 115 119 10.1002/ana.10618 12838527 (Pubitemid 36764988)
-
(2003)
Annals of Neurology
, vol.54
, Issue.1
, pp. 115-119
-
-
Han, X.1
Fagan, A.M.2
Cheng, H.3
Morris, J.C.4
Xiong, C.5
Holtzman, D.M.6
-
90
-
-
70350393282
-
Subcortical vascular dementia biomarker pattern in mild cognitive impairment
-
10.1159/000252773 19864909
-
Subcortical vascular dementia biomarker pattern in mild cognitive impairment. Bjerke M, Andreasson U, Rolstad S, Nordlund A, Lind K, Zetterberg H, Edman A, Blennow K, Wallin A, Dement Geriatr Cogn Disord 2009 28 348 356 10.1159/000252773 19864909
-
(2009)
Dement Geriatr Cogn Disord
, vol.28
, pp. 348-356
-
-
Bjerke, M.1
Andreasson, U.2
Rolstad, S.3
Nordlund, A.4
Lind, K.5
Zetterberg, H.6
Edman, A.7
Blennow, K.8
Wallin, A.9
-
91
-
-
0034815757
-
Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia
-
DOI 10.1016/S0047-6374(01)00306-2, PII S0047637401003062
-
Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia. Wallin A, Sjogren M, Mech Ageing Dev 2001 122 1937 1949 10.1016/S0047-6374(01)00306-2 11589912 (Pubitemid 32925104)
-
(2001)
Mechanisms of Ageing and Development
, vol.122
, Issue.16
, pp. 1937-1949
-
-
Wallin, A.1
Sjogren, M.2
-
92
-
-
82555184961
-
Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease
-
21860087
-
Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease. Bjerke M, Zetterberg H, Edman A, Blennow K, Wallin A, Andreasson U, J Alzheimers Dis 2011 27 665 676 21860087
-
(2011)
J Alzheimers Dis
, vol.27
, pp. 665-676
-
-
Bjerke, M.1
Zetterberg, H.2
Edman, A.3
Blennow, K.4
Wallin, A.5
Andreasson, U.6
-
93
-
-
0034846419
-
White matter damage is associated with matrix metalloproteinases in vascular dementia
-
10.1161/01.STR.32.5.1162 11340226
-
White matter damage is associated with matrix metalloproteinases in vascular dementia. Rosenberg GA, Sullivan N, Esiri MM, Stroke 2001 32 1162 1168 10.1161/01.STR.32.5.1162 11340226
-
(2001)
Stroke
, vol.32
, pp. 1162-1168
-
-
Rosenberg, G.A.1
Sullivan, N.2
Esiri, M.M.3
-
94
-
-
7944234032
-
Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease
-
10.1161/01.STR.0000127420.10990.76 15105518
-
Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Adair JC, Charlie J, Dencoff JE, Kaye JA, Quinn JF, Camicioli RM, Stetler-Stevenson WG, Rosenberg GA, Stroke 2004 35 159 e162 10.1161/01.STR.0000127420.10990.76 15105518
-
(2004)
Stroke
, vol.35
-
-
Adair, J.C.1
Charlie, J.2
Dencoff, J.E.3
Kaye, J.A.4
Quinn, J.F.5
Camicioli, R.M.6
Stetler-Stevenson, W.G.7
Rosenberg, G.A.8
-
95
-
-
42549130059
-
Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration
-
10.1007/s00415-008-0737-6 18204920
-
Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration. Galimberti D, Venturelli E, Fenoglio C, Guidi I, Villa C, Bergamaschini L, Cortini F, Scalabrini D, Baron P, Vergani C, Bresolin N, Scarpini E, J Neurol 2008 255 539 544 10.1007/s00415-008-0737-6 18204920
-
(2008)
J Neurol
, vol.255
, pp. 539-544
-
-
Galimberti, D.1
Venturelli, E.2
Fenoglio, C.3
Guidi, I.4
Villa, C.5
Bergamaschini, L.6
Cortini, F.7
Scalabrini, D.8
Baron, P.9
Vergani, C.10
Bresolin, N.11
Scarpini, E.12
-
96
-
-
0029417080
-
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
-
10.1016/0304-3940(95)12192-7 8787820
-
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Blum-Degen D, Müller T, Kuhn W, Gerlach M, Przuntek H, Riederer P, Neurosci Lett 1995 202 17 20 10.1016/0304-3940(95)12192-7 8787820
-
(1995)
Neurosci Lett
, vol.202
, pp. 17-20
-
-
Blum-Degen, D.1
Müller, T.2
Kuhn, W.3
Gerlach, M.4
Przuntek, H.5
Riederer, P.6
-
97
-
-
79952199815
-
Does executive impairment define a frontal variant of Alzheimer's disease?
-
10.1017/S1041610210001596 20719041
-
Does executive impairment define a frontal variant of Alzheimer's disease? Woodward M, Brodaty H, Boundy K, Ames D, Blanch G, Balshaw R, Int Psychogeriatr 2010 22 1280 1290 10.1017/S1041610210001596 20719041
-
(2010)
Int Psychogeriatr
, vol.22
, pp. 1280-1290
-
-
Woodward, M.1
Brodaty, H.2
Boundy, K.3
Ames, D.4
Blanch, G.5
Balshaw, R.6
-
98
-
-
77952954834
-
Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies
-
10.1016/j.parkreldis.2010.02.015 20338799
-
Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies. Johansen KK, White LR, Sando SB, Aasly JO, Parkinsonism Relat Disord 2010 16 307 315 10.1016/j.parkreldis.2010.02.015 20338799
-
(2010)
Parkinsonism Relat Disord
, vol.16
, pp. 307-315
-
-
Johansen, K.K.1
White, L.R.2
Sando, S.B.3
Aasly, J.O.4
-
99
-
-
77953716788
-
Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
-
10.1136/jnnp.2009.197483 20522869
-
Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease. Kasuga K, Tokutake T, Ishikawa A, Uchiyama T, Tokuda T, Onodera O, Nishizawa M, Ikeuchi T, J Neurol Neurosurg Psychiatry 2010 81 608 610 10.1136/jnnp.2009.197483 20522869
-
(2010)
J Neurol Neurosurg Psychiatry
, vol.81
, pp. 608-610
-
-
Kasuga, K.1
Tokutake, T.2
Ishikawa, A.3
Uchiyama, T.4
Tokuda, T.5
Onodera, O.6
Nishizawa, M.7
Ikeuchi, T.8
-
100
-
-
77958071837
-
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: The Norwegian ParkWest study
-
10.1136/jnnp.2009.199950 20547614
-
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. Alves G, Brønnick K, Aarsland D, Blennow K, Zetterberg H, Ballard C, Kurz MW, Andreasson U, Tysnes O-B, Larsen JP, Mulugeta E, J Neurol Neurosurg Psychiatry 2010 81 1080 1086 10.1136/jnnp.2009.199950 20547614
-
(2010)
J Neurol Neurosurg Psychiatry
, vol.81
, pp. 1080-1086
-
-
Alves, G.1
Brønnick, K.2
Aarsland, D.3
Blennow, K.4
Zetterberg, H.5
Ballard, C.6
Kurz, M.W.7
Andreasson, U.8
Tysnes, O.-B.9
Larsen, J.P.10
Mulugeta, E.11
-
101
-
-
72849127362
-
Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease
-
10.1002/mds.22594 19795497
-
Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease. Compta Y, Martí MJ, Ibarretxe-Bilbao N, Junqué C, Valldeoriola F, Muñoz E, Cho MK, Ríos J, Tolosa E, Mov Disord 2009 24 2203 2210 10.1002/mds.22594 19795497
-
(2009)
Mov Disord
, vol.24
, pp. 2203-2210
-
-
Compta, Y.1
Martí, M.J.2
Ibarretxe-Bilbao, N.3
Junqué, C.4
Valldeoriola, F.5
Muñoz, E.6
Cho, M.K.7
Ríos, J.8
Tolosa, E.9
-
102
-
-
32544446902
-
1-40 in cerebrospinal fluid of patients with dementia with Lewy bodies
-
DOI 10.1515/CCLM.2006.035
-
Total tau protein, phosphorylated tau (181p) protein, β-amyloid1-42, and β-amyloid1-40 in cerebrospinal fluid of patients with dementia with Lewy bodies. Mollenhauer B, Bibl M, Wiltfang J, Steinacker P, Ciesielczyk B, Neubert K, Trenkwalder C, Otto M, Clin Chem Lab Med 2006 44 192 195 16475906 (Pubitemid 43237964)
-
(2006)
Clinical Chemistry and Laboratory Medicine
, vol.44
, Issue.2
, pp. 192-195
-
-
Mollenhauer, B.1
Bibl, M.2
Wiltfang, J.3
Steinacker, P.4
Ciesielczyk, B.5
Neubert, K.6
Trenkwalder, C.7
Otto, M.8
-
103
-
-
33646266021
-
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
-
10.1093/brain/awl063 16600985
-
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia. Bibl M, Mollenhauer B, Esselmann H, Lewczuk P, Klafki H-W, Sparbier K, Smirnov A, Cepek L, Trenkwalder C, Rüther E, Kornhuber J, Otto M, Wiltfang J, Brain 2006 129 1177 1187 10.1093/brain/awl063 16600985
-
(2006)
Brain
, vol.129
, pp. 1177-1187
-
-
Bibl, M.1
Mollenhauer, B.2
Esselmann, H.3
Lewczuk, P.4
Klafki, H.-W.5
Sparbier, K.6
Smirnov, A.7
Cepek, L.8
Trenkwalder, C.9
Rüther, E.10
Kornhuber, J.11
Otto, M.12
Wiltfang, J.13
-
104
-
-
47049100511
-
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies
-
10.1016/j.biopsych.2008.02.016 18395699
-
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P, Biol Psychiatry 2008 64 850 855 10.1016/j.biopsych.2008.02.016 18395699
-
(2008)
Biol Psychiatry
, vol.64
, pp. 850-855
-
-
Parnetti, L.1
Tiraboschi, P.2
Lanari, A.3
Peducci, M.4
Padiglioni, C.5
D'Amore, C.6
Pierguidi, L.7
Tambasco, N.8
Rossi, A.9
Calabresi, P.10
-
105
-
-
40949119905
-
Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases
-
DOI 10.1016/j.ymeth.2007.06.012, PII S1046202307001259
-
Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases. Otto M, Lewczuk P, Wiltfang J, Methods 2008 44 289 298 10.1016/j.ymeth.2007.06.012 18374272 (Pubitemid 351406506)
-
(2008)
Methods
, vol.44
, Issue.4
, pp. 289-298
-
-
Otto, M.1
Lewczuk, P.2
Wiltfang, J.3
-
106
-
-
77952477706
-
Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: United we stand, divided we fall
-
20201744
-
Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall. Mattsson N, Blennow K, Zetterberg H, Clin Chem Lab Med 2010 48 603 607 20201744
-
(2010)
Clin Chem Lab Med
, vol.48
, pp. 603-607
-
-
Mattsson, N.1
Blennow, K.2
Zetterberg, H.3
-
107
-
-
84865507286
-
Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers
-
10.2217/bmm.12.41 22917142
-
Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers. Mattsson N, Andreasson U, Carrillo MC, Persson S, Shaw LM, Zegers I, Zetterberg H, Blennow K, Biomark Med 2012 6 401 407 10.2217/bmm.12.41 22917142
-
(2012)
Biomark Med
, vol.6
, pp. 401-407
-
-
Mattsson, N.1
Andreasson, U.2
Carrillo, M.C.3
Persson, S.4
Shaw, L.M.5
Zegers, I.6
Zetterberg, H.7
Blennow, K.8
|